We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock

Delisted

YTEN was delisted on the 15th of May, 2024.

8 hedge funds and large institutions have $1.61M invested in Yield10 Bioscience, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 88 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

46% less capital invested

Capital invested by funds: $2.95M → $1.61M (-$1.34M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

YTEN Hedge Fund Activity: Q3 2016 in Review

8 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2016, worth a combined $1.61M — down 46% from $2.95M a quarter earlier.

Fund positioning in YTEN was balanced in Q3 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was FCG Advisors, adding an estimated $20.3K. The largest seller was Vanguard Group, cutting an estimated $15.2K.

  • 8 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $1.61M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2016, down 46% quarter-over-quarter.
  • 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2016 and 1 closed out, a net change of 0 holders.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2016 was FCG Advisors, an estimated $20.3K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2016 was Vanguard Group, an estimated $15.2K sold.

Based on aggregated 13F filings for Q3 2016.